SHARE:

< Back to Search

Neurology® Podcast - April 8 2014 Issue

Fingolimod after natalizumab and the risk of short-term relapse

1) Fingolimod after natalizumab and the risk of short-term relapse and 2) Topic of the month: Therapeutics in epilepsy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interviews Dr. Vilija Jokubaitis about her paper on fingolimod after natalizumab and the risk of short-term relapse. Dr. Adam Numis is reading our e-Pearl of the week about cardiac cephalgia. In the next part of the podcast Dr. Lara Marcuse interviews Dr. Madeline Fields about epilepsy therapeutics: Clobazam. Read More

Download this Episode

Episode Segments

Introduction (00:19 - 00:44)
00:19 00:44

Play Segment

Interview-Fingolimod after natalizumab and the risk of short-term relapse (00:45 - 09:44)
ePearl 1-cardiac cephalgia (09:45 - 11:02)
LOTW- epilepsy therapeutics: Clobazam (11:03 - 19:43)
ePearl 2-cardiac cephalgia (19:44 - 20:33)
Closing (20:34 - 22:44)
20:34 22:44

Play Segment

Log On

MEMBER LOG IN

Forgot password?

**Due to required system maintenance on AAN.com, some functions may be unavailable Friday, 12/15/2017, through Monday, 12/18/2017. Thank you for your patience.**